Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Achillion Pharmaceuticals Inc (NASDAQ:ACHN)

7.78
Delayed Data
As of Jun 28
 +0.30 / +4.01%
Today’s Change
5.57
Today|||52-Week Range
10.95
-27.90%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2012

2013

2014

2015
Revenue and IncomeNet Revenues2.6M0.000.0066.1M
 
 
 
Depreciation And Amortization408.0K399.0K489.0K694.0K
 
 
 
 
 
 
Operating ExpensesGross Income---399.0K-489.0K--
 
 
 
General Expenses50.0M59.1M69.6M81.2M
 
 
 
 
 
Research And Development39.6M46.7M54.2M57.2M
 
 
 
 
 
Total Operating Expenses50.5M59.5M70.1M81.9M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-47.8M-59.5M-70.1M-15.7M
 
 
 
 
 
Interest Expense On Debt68.0K52.0K37.0K55.0K
 
 
 
 
 
Other Expenses0.000.000.008.9M
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-47.7M-58.9M-69.7M-5.7M
 
 
 
 
 
Income Taxes-554.0K0.00-678.0K-640.0K
 
 
 
 
Net Income-47.1M-58.9M-69.0M-5.0M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS74.0M94.0M98.4M125.6M
 
 
 
 
 
Shares To Calculate EPS Diluted74.0M94.0M98.4M125.6M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.64-$0.63-$0.70-$0.04
 
 
 
 
 
EPS Diluted-$0.64-$0.63-$0.70-$0.04